Overview

The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures.

The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics.

Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.

Eligibility

Inclusion Criteria:

• Subject is ≥ 22 years of age on the day of surgery.
• Subject is scheduled to undergo a unilateral primary arthroplasty procedure on a hip or knee.
• Subject is capable of providing informed consent.
• Subject is willing and able to return for all visits.

Exclusion Criteria:

• Subject is pregnant or lactating prior to surgery.\*

  \*Women who have had surgical sterilization by a medically accepted method (e.g., tubal ligation, hysterectomy, or oophorectomy) or are post-menopausal, defined as not having menstruation for \> 12 months will not be required to undergo pregnancy testing

• Subject is scheduled to undergo a lower extremity bilateral arthroplasty procedure.
• Subject had a previous open knee surgery on the study knee or is scheduled to undergo a revision knee arthroplasty.
• Subject has had a previous surgery for revision femoral acetabular osteotomy or total hip arthroplasty on the study hip.
• Subject is scheduled for lower extremity arthroplasty due to trauma.
• Subject was previously diagnosed with septic arthritis or has a history of infection in the joint.
• Subject has taken any antibiotics within 4 weeks before surgery.
• Subject has an allergy or sensitivity to components of the device (e.g., chlorhexidine gluconate or acrylate-based adhesive).
• Subject is currently enrolled in another trial.